miRNA biogenesis-associated RNase III nucleases Drosha and Dicer are upregulated in colorectal adenocarcinoma

Shin Kim1,2, Mei Ling Song3, Hyeonji Min1

  • 1Department of Immunology, School of Medicine, Keimyung University, Dalseo, Daegu 42601, Republic of Korea.

Oncology Letters
|September 26, 2017
PubMed

Insights

Drosha and Dicer, key microRNA regulators, are significantly upregulated in colorectal cancer (CRC) tissues. Their expression levels in CRC did not correlate with clinical features or each other.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Drosha and Dicer are crucial enzymes in microRNA (miRNA) biogenesis.
  • Aberrant regulation of these enzymes is implicated in colorectal cancer (CRC) development.
  • Understanding their role in CRC pathogenesis is vital for potential therapeutic strategies.

Purpose of the Study:

  • To investigate the messenger RNA (mRNA) expression levels of Drosha and Dicer in colorectal cancer (CRC) specimens.
  • To determine the association between Drosha and Dicer mRNA expression and clinical features in CRC patients.
  • To explore the relationship between Drosha and Dicer mRNA expression levels in CRC.

Main Methods:

  • Quantitative polymerase chain reaction (qPCR) was used to measure Drosha and Dicer mRNA expression.
  • The study analyzed 77 colorectal cancer (CRC) tissues and adjacent non-neoplastic tissues.
  • Clinical data including sex, age, TNM stage, BMI, and CEA levels were collected.

Main Results:

  • Drosha and Dicer mRNA expression levels were significantly upregulated in colorectal cancer (CRC) tissues compared to non-neoplastic tissues.
  • No significant association was found between Drosha or Dicer mRNA expression levels and clinical parameters (sex, age, TNM stage, BMI, CEA).
  • There was no significant correlation between the expression levels of Drosha and Dicer mRNA in CRC specimens.

Conclusions:

  • The study demonstrates significant upregulation of Drosha and Dicer mRNA in colorectal cancer (CRC).
  • These findings suggest that Drosha and Dicer play a role in the pathobiology of colorectal carcinogenesis.
  • Further research is warranted to elucidate the precise mechanisms and clinical implications of Drosha and Dicer dysregulation in CRC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.0K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.2K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.7K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.8K